Intra-Cellular Therapies (ITCI) Announces $350M Public Offering of Common Stock
Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment for certain bipolar disorders, ITCI stock surged 73% on Wednesday. Intra-Cellular Therapies, Inc. (ITCI) stock made a massive move on Wednesday surging up to 73% at close. The stock price sky-rocketed initially from the update […]
5 Active Stocks to Trade Today
The market rebounded yesterday after several days of declines. Tech stocks drove the rebound rally with the Nasdaq advancing 2.7%, while the S&P 500 and DJIA posted gains of 2.0% and 1.6%, respectively. The ‘Tech Wreck’ took a pause yesterday, but the relief doesn’t look like it will last long. Futures are pointing to a […]
